Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Identifying risk factor for development of perioperative venous thromboembolism in patients with gastrointestinal malignancy.

Bhutiani N, Quinn SA, Mercer MK, Hong YK, Stevenson M, Egger ME, Philips P, McMasters KM, Martin RCG 2nd, Scoggins CR.

Am J Surg. 2019 Aug;218(2):311-314. doi: 10.1016/j.amjsurg.2019.02.008. Epub 2019 Feb 12.

PMID:
30795857
2.

Phf6 Loss Enhances HSC Self-Renewal Driving Tumor Initiation and Leukemia Stem Cell Activity in T-ALL.

Wendorff AA, Quinn SA, Rashkovan M, Madubata CJ, Ambesi-Impiombato A, Litzow MR, Tallman MS, Paietta E, Paganin M, Basso G, Gastier-Foster JM, Loh ML, Rabadan R, Van Vlierberghe P, Ferrando AA.

Cancer Discov. 2019 Mar;9(3):436-451. doi: 10.1158/2159-8290.CD-18-1005. Epub 2018 Dec 19.

PMID:
30567843
3.

The impact of enhanced recovery pathways on cost of care and perioperative outcomes in patients undergoing gastroesophageal and hepatopancreatobiliary surgery.

Bhutiani N, Quinn SA, Jones JM, Mercer MK, Philips P, McMasters KM, Scoggins CR, Martin RCG 2nd.

Surgery. 2018 Oct;164(4):719-725. doi: 10.1016/j.surg.2018.05.035. Epub 2018 Jul 30.

PMID:
30072252
4.

RHOA G17V Induces T Follicular Helper Cell Specification and Promotes Lymphomagenesis.

Cortes JR, Ambesi-Impiombato A, Couronné L, Quinn SA, Kim CS, da Silva Almeida AC, West Z, Belver L, Martin MS, Scourzic L, Bhagat G, Bernard OA, Ferrando AA, Palomero T.

Cancer Cell. 2018 Feb 12;33(2):259-273.e7. doi: 10.1016/j.ccell.2018.01.001. Epub 2018 Feb 2.

5.

Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas.

Abate F, da Silva-Almeida AC, Zairis S, Robles-Valero J, Couronne L, Khiabanian H, Quinn SA, Kim MY, Laginestra MA, Kim C, Fiore D, Bhagat G, Piris MA, Campo E, Lossos IS, Bernard OA, Inghirami G, Pileri S, Bustelo XR, Rabadan R, Ferrando AA, Palomero T.

Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):764-769. doi: 10.1073/pnas.1608839114. Epub 2017 Jan 6.

6.

Phase I/II prospective trial of cancer-specific imaging using ultrasound spectrum analysis tissue-type imaging to guide dose-painting prostate brachytherapy.

Ennis RD, Quinn SA, Trichter F, Ryemon S, Jain A, Saigal K, Chandrashekhar S, Romas NA, Feleppa EJ.

Brachytherapy. 2015 Nov-Dec;14(6):801-8. doi: 10.1016/j.brachy.2015.06.011. Epub 2015 Jul 31.

PMID:
26235201
7.

The Impact of Economic Recession on the Incidence and Treatment of Cancer.

Ennis KY, Chen MH, Smith GC, D'Amico AV, Zhang Y, Quinn SA, Ryemon SN, Goltz D, Harrison LB, Ennis RD.

J Cancer. 2015 Jun 24;6(8):727-33. doi: 10.7150/jca.11886. eCollection 2015.

8.

A targetable GATA2-IGF2 axis confers aggressiveness in lethal prostate cancer.

Vidal SJ, Rodriguez-Bravo V, Quinn SA, Rodriguez-Barrueco R, Lujambio A, Williams E, Sun X, de la Iglesia-Vicente J, Lee A, Readhead B, Chen X, Galsky M, Esteve B, Petrylak DP, Dudley JT, Rabadan R, Silva JM, Hoshida Y, Lowe SW, Cordon-Cardo C, Domingo-Domenech J.

Cancer Cell. 2015 Feb 9;27(2):223-39. doi: 10.1016/j.ccell.2014.11.013.

9.

Prostate cancer: muddying the waters by overlooking treatment modality.

Ennis RD, Quinn SA.

Nat Rev Clin Oncol. 2014 Jun;11(6):305-7. doi: 10.1038/nrclinonc.2014.52. Epub 2014 Apr 1. No abstract available.

PMID:
24687032
10.

Isolation of cancer stem cells from human prostate cancer samples.

Vidal SJ, Quinn SA, de la Iglesia-Vicente J, Bonal DM, Rodriguez-Bravo V, Firpo-Betancourt A, Cordon-Cardo C, Domingo-Domenech J.

J Vis Exp. 2014 Mar 14;(85). doi: 10.3791/51332.

11.

Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells.

Domingo-Domenech J, Vidal SJ, Rodriguez-Bravo V, Castillo-Martin M, Quinn SA, Rodriguez-Barrueco R, Bonal DM, Charytonowicz E, Gladoun N, de la Iglesia-Vicente J, Petrylak DP, Benson MC, Silva JM, Cordon-Cardo C.

Cancer Cell. 2012 Sep 11;22(3):373-88. doi: 10.1016/j.ccr.2012.07.016.

12.
13.

Unusual presentation of metastatic carcinoma to the eye.

Milman T, Iacob C, Rosen RB, Farrell GM, Quinn SA, Cohen BZ, McCormick SA.

Retin Cases Brief Rep. 2010 Winter;4(1):65-9. doi: 10.1097/ICB.0b013e31818f6527.

PMID:
25390125
14.

Treatment of tinnitus with a customized, dynamic acoustic neural stimulus: clinical outcomes in general private practice.

Hanley PJ, Davis PB, Paki B, Quinn SA, Bellekom SR.

Ann Otol Rhinol Laryngol. 2008 Nov;117(11):791-9.

PMID:
19102123
15.

Does heparin prophylaxis prevent exacerbations of hereditary angioedema?

Weiler JM, Quinn SA, Woodworth GG, Brown DD, Layton TA, Maves KK.

J Allergy Clin Immunol. 2002 Jun;109(6):995-1000.

PMID:
12063530
16.

Accuracy of references in research quarterly for exercise and sport.

Stull GA, Christina RW, Quinn SA.

Res Q Exerc Sport. 1991 Sep;62(3):245-8. No abstract available.

PMID:
1925051

Supplemental Content

Loading ...
Support Center